MADIHA SALIM

Allopathic & Osteopathic Physicians|Internal Medicine WALLED LAKE, MI NPI 1760845895

General Payments — all program years on this page

$1,973.12

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 103
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $428.86 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $428.8620

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2020 $27.442
2021 $523.3923
2022 $498.3930
2023 $495.0428
2024 $428.8620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087329039 Novartis Pharmaceuticals Corporation $20.26 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097432231 Novo Nordisk Inc $19.63 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097811324 Novo Nordisk Inc $15.64 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101614853 E.R. Squibb & Sons, L.L.C. $16.97 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104265167 AstraZeneca Pharmaceuticals LP $13.22 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104377945 AstraZeneca Pharmaceuticals LP $16.51 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104411827 AstraZeneca Pharmaceuticals LP $88.91 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104484322 AstraZeneca Pharmaceuticals LP $16.71 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104696370 AstraZeneca Pharmaceuticals LP $15.68 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105557544 AstraZeneca Pharmaceuticals LP $28.20 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105560528 AstraZeneca Pharmaceuticals LP $13.97 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105797248 AstraZeneca Pharmaceuticals LP $16.08 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105805714 AstraZeneca Pharmaceuticals LP $16.74 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106006684 ABBVIE INC. $16.61 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106006686 ABBVIE INC. $26.65 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116524214 GlaxoSmithKline, LLC. $21.61 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118145058 Boehringer Ingelheim Pharmaceuticals, Inc. $14.57 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135152992 Lilly USA, LLC $17.42 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151119650 Phathom Pharmaceuticals, Inc. $18.48 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151119652 Phathom Pharmaceuticals, Inc. $15.00 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.